Therapeutic Advances in Endocrinology and Metabolism
#pharmaceuticals #patents #drugdevelopment #biotech #smallmolecule #patentlaw #pharmapatents #drugpatents #innovation #intellectualproperty To view or add a comment, sign in Lipitor made $125 billion before patent expiry
Ankit Patel (BHMS, DNHE) | Published: May 27, 2026 | Updated based on CDSCO Public Notice, May 18, 2026 If you've been visiting a skin clinic for glutathione drips, or were planning to try one, you need to read this first
It tends to happen more gradually over time, to the point where you may not notice the changes right away or that they are even significant, explains Garshick
The whole point of this kind of approach is that it can move quickly, and thats exactly when its most valuable, says Guntuku
The complaint alleges that Novo Nordisk was negligent in allowing Ozempic to be sold, failed to warn, negligently designed Ozempic and other semaglutide drugs, negligently marketed the drug, and violated Pennsylvania unfair trade practices